Diabetes News

Fetal growth rate is higher for women with gestational diabetes in the third trimester, and that accelerated growth rate may contribute to an increased likelihood for overweight among children, according to study data from Denmark.

The Mayo Clinic in Rochester, Minnesota, has repeated as the No. 1 hospital in the U.S. for diabetes and endocrinology, according to the U.S. News & World Report’s 2024-2025 Best Hospitals rankings.

Children with presymptomatic type 1 diabetes progressed more quickly to type 1 diabetes after having COVID-19, according to a research letter published in JAMA.

Metabolic dysfunction-associated steatotic liver disease affects more than one-third of the world’s population and is associated with significant clinical and economic burden, as well as impairment of health-related quality of life.

To put it simply, diabetes and steatotic liver disease are joined at the hip. They are part of the same biological process that involves multiple organs, connected by the concept of metabolic flexibility — or lack thereof.

Metabolic dysfunction-associated steatohepatitis is significantly more common in patients with type 2 diabetes, and most patients with MASH — formerly known as NASH — experience metabolic abnormalities, including obesity.

Metabolic dysfunction-associated steatotic liver disease is a public health threat, affecting 30% to 38% of the adult population globally. The prevalence has risen in parallel with epidemics of obesity and type 2 diabetes.

Millions of dollars have been spent trying to find medications that could treat this complex disorder. The focus has been on drugs for more severe disease, as it leads to complications, and early stages have been somewhat ignored.

People who delayed diabetes through diet and exercise for at least 4 years after their prediabetes diagnosis had a lower risk for death and other adverse outcomes vs. those who were diagnosed with diabetes during that time, a study showed.